Literature DB >> 10415060

Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.

H E Thomas1, R Darwiche, J A Corbett, T W Kay.   

Abstract

Recent studies suggest that Fas expression on pancreatic beta cells may be important in the development of autoimmune diabetes in the nonobese diabetic (NOD) mouse. To address this, pancreatic islets from NOD mice were analyzed by flow cytometry to directly identify which cells express Fas and Fas ligand (FasL) ex vivo and after in vitro culture with cytokines. Fas expression was not detected on beta cells isolated from young (35 days) NOD mice. In vitro, incubation of NOD mouse islets with both IL-1 and IFN-gamma was required to achieve sufficient Fas expression and sensitivity for islets to be susceptible to lysis by soluble FasL. In islets isolated from older (>/=125 days) NOD mice, Fas expression was detected on a limited number of beta cells (1-5%). FasL was not detected on beta cells from either NOD or Fas-deficient MRLlpr/lpr islets. Also, both NOD and MRLlpr/lpr islets were equally susceptible to cytokine-induced cell death. This eliminates the possibility that cytokine-treated murine islet cells commit "suicide" due to simultaneous expression of Fas and FasL. Last, we show that NO is not required for cytokine-induced Fas expression and Fas-mediated apoptosis of islet cells. These findings indicate that beta cells can be killed by Fas-dependent cytotoxicity; however, our results raise further doubts about the clinical significance of Fas-mediated beta cell destruction because few Fas-positive cells were isolated immediately before the development of diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes.

Authors:  S Uno; A Imagawa; K Okita; K Sayama; M Moriwaki; H Iwahashi; K Yamagata; S Tamura; Y Matsuzawa; T Hanafusa; J Miyagawa; I Shimomura
Journal:  Diabetologia       Date:  2007-01-13       Impact factor: 10.122

3.  A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.

Authors:  Ming S Lin; Hubert M Tse; Meghan M Delmastro; Suzanne Bertera; Caterina T Wong; Robert Lakomy; Jing He; Martha M Sklavos; Gina M Coudriet; Massimo Pietropaolo; Massimo M Trucco; Jon D Piganelli
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

4.  IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

Authors:  A Amrani; J Verdaguer; S Thiessen; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  Localized immune tolerance from FasL-functionalized PLG scaffolds.

Authors:  Michael Skoumal; Kyle B Woodward; Hong Zhao; Feng Wang; Esma S Yolcu; Ryan M Pearson; Kevin R Hughes; Andrés J García; Lonnie D Shea; Haval Shirwan
Journal:  Biomaterials       Date:  2018-11-13       Impact factor: 12.479

6.  Apoptosis in autoimmune diabetes: the fate of beta-cells in the cleft between life and death.

Authors:  Charles Sia; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2006-05-10

Review 7.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

8.  Innovative Microcapsules for Pancreatic β-Cells Harvested from Mature Double-Transgenic Mice: Cell Imaging, Viability, Induced Glucose-Stimulated Insulin Measurements and Proinflammatory Cytokines Analysis.

Authors:  Armin Mooranian; Ryu Tackechi; Emma Jamieson; Grant Morahan; Hani Al-Salami
Journal:  Pharm Res       Date:  2017-03-13       Impact factor: 4.200

9.  Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.

Authors:  Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

10.  Islet beta-cells deficient in Bcl-xL develop but are abnormally sensitive to apoptotic stimuli.

Authors:  Emma M Carrington; Mark D McKenzie; Elisa Jansen; Michelle Myers; Stacey Fynch; Cameron Kos; Andreas Strasser; Thomas W Kay; Clare L Scott; Janette Allison
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.